Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun He

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Plos One|January 18, 2013
The identification of CD163 expressing phagocytic chondrocytes in joint cartilage and its novel scavenger role in cartilage degradationKai Jiao, Jing Zhang, Mian Zhang, et al.
Breast (Edinburgh, Scotland)|April 30, 2024
Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapyRu Wang, Bin Wang, Huimin Zhang, et al.
Plos One|November 27, 2013
A nation-wide multicenter retrospective study of the epidemiological, pathological and clinical characteristics of breast cancer in situ in Chinese women in 1999 - 2008Yanan Kong, Lu Yang, Hailin Tang, et al.
Diagnostic Pathology|May 6, 2019
A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological studyHuimin Zhang, Peiling Xie, Zhuoying Li, et al.
Health and Quality of Life Outcomes|March 25, 2016
Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional studyAyong Cao, Jin Zhang, Xiaoan Liu, et al.
Public Health|February 20, 2026
The impact of DRG payment reform on hospitalization costs and length of stay: A multicenter study across different hospital levels and departmentsZhican Liu, Lishu Zhou, Lingling Zhang, et al.
Iscience|July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world studyFengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Therapeutic Advances in Medical Oncology|March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapyAmina Maimaitiaili, Heyan Chen, Peiling Xie, et al.
Frontiers in Oncology|May 27, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)Amina Maimaitiaili, Yijun Li, Na Chai, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Plos One|January 18, 2013
The identification of CD163 expressing phagocytic chondrocytes in joint cartilage and its novel scavenger role in cartilage degradationKai Jiao, Jing Zhang, Mian Zhang, et al.
Breast (Edinburgh, Scotland)|April 30, 2024
Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapyRu Wang, Bin Wang, Huimin Zhang, et al.
Plos One|November 27, 2013
A nation-wide multicenter retrospective study of the epidemiological, pathological and clinical characteristics of breast cancer in situ in Chinese women in 1999 - 2008Yanan Kong, Lu Yang, Hailin Tang, et al.
Diagnostic Pathology|May 6, 2019
A nomogram for predicting the HER2 status in female patients with breast cancer in China: a nationwide, multicenter, 10-year epidemiological studyHuimin Zhang, Peiling Xie, Zhuoying Li, et al.
Health and Quality of Life Outcomes|March 25, 2016
Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional studyAyong Cao, Jin Zhang, Xiaoan Liu, et al.
Public Health|February 20, 2026
The impact of DRG payment reform on hospitalization costs and length of stay: A multicenter study across different hospital levels and departmentsZhican Liu, Lishu Zhou, Lingling Zhang, et al.
Iscience|July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world studyFengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Therapeutic Advances in Medical Oncology|March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Journal of Cancer Research and Clinical Oncology|May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapyAmina Maimaitiaili, Heyan Chen, Peiling Xie, et al.
Frontiers in Oncology|May 27, 2024
A nomogram for predicting pathologic node negativity after neoadjuvant chemotherapy in breast cancer patients: a nationwide, multicenter retrospective cohort study (CSBrS-012)Amina Maimaitiaili, Yijun Li, Na Chai, et al.
Pageof 22